c	0	1	B-Gene_or_gene_product
-	1	2	I-Gene_or_gene_product
Ski	2	5	I-Gene_or_gene_product
overexpression	6	20	O
promotes	21	29	O
tumor	30	35	B-Pathological_formation
growth	36	42	O
and	43	46	O
angiogenesis	47	59	O
through	60	67	O
inhibition	68	78	O
of	79	81	O
transforming	82	94	B-Gene_or_gene_product
growth	95	101	I-Gene_or_gene_product
factor	102	108	I-Gene_or_gene_product
-	108	109	I-Gene_or_gene_product
beta	109	113	I-Gene_or_gene_product
signaling	114	123	O
in	124	126	O
diffuse	127	134	O
-	134	135	O
type	135	139	O
gastric	140	147	B-Pathological_formation
carcinoma	148	157	I-Pathological_formation
.	157	158	O

c	160	161	B-Gene_or_gene_product
-	161	162	I-Gene_or_gene_product
Ski	162	165	I-Gene_or_gene_product
,	165	166	O
originally	167	177	O
identified	178	188	O
as	189	191	O
a	192	193	O
proto	194	199	O
-	199	200	O
oncogene	200	208	O
product	209	216	O
,	216	217	O
is	218	220	O
an	221	223	O
important	224	233	O
negative	234	242	O
regulator	243	252	O
of	253	255	O
transforming	256	268	B-Gene_or_gene_product
growth	269	275	I-Gene_or_gene_product
factor	276	282	I-Gene_or_gene_product
(	283	284	I-Gene_or_gene_product
TGF	284	287	I-Gene_or_gene_product
)	287	288	I-Gene_or_gene_product
-	288	289	I-Gene_or_gene_product
beta	289	293	I-Gene_or_gene_product
family	294	300	O
signaling	301	310	O
through	311	318	O
interaction	319	330	O
with	331	335	O
Smad2	336	341	B-Gene_or_gene_product
,	341	342	O
Smad3	343	348	B-Gene_or_gene_product
,	348	349	O
and	350	353	O
Smad4	354	359	B-Gene_or_gene_product
.	359	360	O

High	361	365	O
expression	366	376	O
of	377	379	O
c	380	381	B-Gene_or_gene_product
-	381	382	I-Gene_or_gene_product
Ski	382	385	I-Gene_or_gene_product
has	386	389	O
been	390	394	O
found	395	400	O
in	401	403	O
some	404	408	O
cancers	409	416	B-Pathological_formation
,	416	417	O
including	418	427	O
gastric	428	435	B-Pathological_formation
cancer	436	442	I-Pathological_formation
.	442	443	O

We	444	446	O
previously	447	457	O
showed	458	464	O
that	465	469	O
disruption	470	480	O
of	481	483	O
TGF	484	487	B-Gene_or_gene_product
-	487	488	I-Gene_or_gene_product
beta	488	492	I-Gene_or_gene_product
signaling	493	502	O
by	503	505	O
dominant	506	514	O
-	514	515	O
negative	515	523	O
TGF	524	527	B-Gene_or_gene_product
-	527	528	I-Gene_or_gene_product
beta	528	532	I-Gene_or_gene_product
type	533	537	I-Gene_or_gene_product
II	538	540	I-Gene_or_gene_product
receptor	541	549	I-Gene_or_gene_product
in	550	552	O
a	553	554	O
diffuse	555	562	O
-	562	563	O
type	563	567	O
gastric	568	575	B-Pathological_formation
carcinoma	576	585	I-Pathological_formation
model	586	591	O
accelerated	592	603	O
tumor	604	609	B-Pathological_formation
growth	610	616	O
through	617	624	O
induction	625	634	O
of	635	637	O
tumor	638	643	B-Pathological_formation
angiogenesis	644	656	O
by	657	659	O
decreased	660	669	O
expression	670	680	O
of	681	683	O
the	684	687	O
anti	688	692	O
-	692	693	O
angiogenic	693	703	O
factor	704	710	O
thrombospondin	711	725	B-Gene_or_gene_product
(	726	727	I-Gene_or_gene_product
TSP	727	730	I-Gene_or_gene_product
)	730	731	I-Gene_or_gene_product
-	731	732	I-Gene_or_gene_product
1	732	733	I-Gene_or_gene_product
.	733	734	O

Here	735	739	O
,	739	740	O
we	741	743	O
examined	744	752	O
the	753	756	O
function	757	765	O
of	766	768	O
c	769	770	B-Gene_or_gene_product
-	770	771	I-Gene_or_gene_product
Ski	771	774	I-Gene_or_gene_product
in	775	777	O
human	778	783	B-Organism
diffuse	784	791	O
-	791	792	O
type	792	796	O
gastric	797	804	B-Pathological_formation
carcinoma	805	814	I-Pathological_formation
OCUM	815	819	B-Cell
-	819	820	I-Cell
2MLN	820	824	I-Cell
cells	825	830	I-Cell
.	830	831	O

Overexpression	832	846	O
of	847	849	O
c	850	851	B-Gene_or_gene_product
-	851	852	I-Gene_or_gene_product
Ski	852	855	I-Gene_or_gene_product
inhibited	856	865	O
TGF	866	869	B-Gene_or_gene_product
-	869	870	I-Gene_or_gene_product
beta	870	874	I-Gene_or_gene_product
signaling	875	884	O
in	885	887	O
OCUM	888	892	B-Cell
-	892	893	I-Cell
2MLN	893	897	I-Cell
cells	898	903	I-Cell
.	903	904	O

Interestingly	905	918	O
,	918	919	O
c	920	921	B-Gene_or_gene_product
-	921	922	I-Gene_or_gene_product
Ski	922	925	I-Gene_or_gene_product
overexpression	926	940	O
resulted	941	949	O
in	950	952	O
extensive	953	962	O
acceleration	963	975	O
of	976	978	O
the	979	982	O
growth	983	989	O
of	990	992	O
subcutaneous	993	1005	O
xenografts	1006	1016	B-Pathological_formation
in	1017	1019	O
BALB	1020	1024	B-Organism
/	1024	1025	I-Organism
c	1025	1026	I-Organism
nu	1027	1029	I-Organism
/	1029	1030	I-Organism
nu	1030	1032	I-Organism
female	1033	1039	I-Organism
mice	1040	1044	I-Organism
(	1045	1046	O
6	1046	1047	O
weeks	1048	1053	O
of	1054	1056	O
age	1057	1060	O
)	1060	1061	O
.	1061	1062	O

Similar	1063	1070	O
to	1071	1073	O
tumors	1074	1080	B-Pathological_formation
expressing	1081	1091	O
dominant	1092	1100	O
-	1100	1101	O
negative	1101	1109	O
TGF	1110	1113	B-Gene_or_gene_product
-	1113	1114	I-Gene_or_gene_product
beta	1114	1118	I-Gene_or_gene_product
type	1119	1123	I-Gene_or_gene_product
II	1124	1126	I-Gene_or_gene_product
receptor	1127	1135	I-Gene_or_gene_product
,	1135	1136	O
histochemical	1137	1150	O
studies	1151	1158	O
revealed	1159	1167	O
less	1168	1172	O
fibrosis	1173	1181	O
and	1182	1185	O
increased	1186	1195	O
angiogenesis	1196	1208	O
in	1209	1211	O
xenografted	1212	1223	O
tumors	1224	1230	B-Pathological_formation
expressing	1231	1241	O
c	1242	1243	B-Gene_or_gene_product
-	1243	1244	I-Gene_or_gene_product
Ski	1244	1247	I-Gene_or_gene_product
compared	1248	1256	O
to	1257	1259	O
control	1260	1267	O
tumors	1268	1274	B-Pathological_formation
.	1274	1275	O

Induction	1276	1285	O
of	1286	1288	O
TSP	1289	1292	B-Gene_or_gene_product
-	1292	1293	I-Gene_or_gene_product
1	1293	1294	I-Gene_or_gene_product
mRNA	1295	1299	O
by	1300	1302	O
TGF	1303	1306	B-Gene_or_gene_product
-	1306	1307	I-Gene_or_gene_product
beta	1307	1311	I-Gene_or_gene_product
was	1312	1315	O
attenuated	1316	1326	O
by	1327	1329	O
c	1330	1331	B-Gene_or_gene_product
-	1331	1332	I-Gene_or_gene_product
Ski	1332	1335	I-Gene_or_gene_product
in	1336	1338	O
vitro	1339	1344	O
,	1344	1345	O
and	1346	1349	O
expression	1350	1360	O
of	1361	1363	O
TSP	1364	1367	B-Gene_or_gene_product
-	1367	1368	I-Gene_or_gene_product
1	1368	1369	I-Gene_or_gene_product
mRNA	1370	1374	O
was	1375	1378	O
decreased	1379	1388	O
in	1389	1391	O
tumors	1392	1398	B-Pathological_formation
expressing	1399	1409	O
c	1410	1411	B-Gene_or_gene_product
-	1411	1412	I-Gene_or_gene_product
Ski	1412	1415	I-Gene_or_gene_product
in	1416	1418	O
vivo	1419	1423	O
.	1423	1424	O

These	1425	1430	O
findings	1431	1439	O
suggest	1440	1447	O
that	1448	1452	O
c	1453	1454	B-Gene_or_gene_product
-	1454	1455	I-Gene_or_gene_product
Ski	1455	1458	I-Gene_or_gene_product
overexpression	1459	1473	O
promotes	1474	1482	O
the	1483	1486	O
growth	1487	1493	O
of	1494	1496	O
diffuse	1497	1504	O
-	1504	1505	O
type	1505	1509	O
gastric	1510	1517	B-Pathological_formation
carcinoma	1518	1527	I-Pathological_formation
through	1528	1535	O
induction	1536	1545	O
of	1546	1548	O
angiogenesis	1549	1561	O
.	1561	1562	O

